{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:13:45Z","timestamp":1792242825157,"version":"4.4.0"},"reference-count":58,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:p>The development of curative therapy for most pediatric malignancies has produced a growing population of childhood cancer survivors who are at increased risk for a variety of health problems resulting from their cancer or its treatment. Because of the fact that many treatment-related sequelae may not become clinically apparent until the survivor attains maturity or begins to age, the ability of primary care providers to anticipate late effects of treatment is essential for providing timely interventions that prevent or correct these sequelae and their adverse effects on quality of life. Altered bone metabolism during treatment for childhood cancer may interfere with attainment of peak bone mass, potentially predisposing to premature onset of and more severe complications related to osteopenia and osteoporosis. Bone mineral deficits have been reported after treatment for a variety of pediatric malignancies and represent morbidity that can be reduced or prevented through lifestyle changes and attention to other common cancer-related sequelae such as hypogonadism. The Children's Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers provide risk-based surveillance recommendations that are based on expert opinion and review of the scientific literature for potential late effects of pediatric cancer therapy including osteopenia. This review summarizes the existing literature that has defined characteristics of cancer survivors at risk for bone mineral deficits and contributed to the surveillance and counseling recommendations outlined in the Children's Oncology group long-term follow-up guidelines.<\/jats:p>","DOI":"10.1542\/peds.2007-1396","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T14:48:09Z","timestamp":1204296489000},"page":"e705-e713","source":"Crossref","is-referenced-by-count":189,"title":["Bone Mineral Density Deficits in Survivors of Childhood Cancer: Long-term Follow-up Guidelines and Review of the Literature"],"prefix":"10.1542","volume":"121","author":[{"given":"Karen","family":"Wasilewski-Masker","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology Oncology, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue C.","family":"Kaste","sequence":"additional","affiliation":[{"name":"Radiological Sciences"},{"name":"Department of Radiology, University of Tennessee School of Health Sciences, Memphis, Tennessee"},{"name":"Hematology Oncology, St Jude Children's Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Hematology Oncology, St Jude Children's Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natia","family":"Esiashvili","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Mattano","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Pediatrics, Michigan State University\/Kalamazoo Center for Medical Studies, Kalamazoo, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian R.","family":"Meacham","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology Oncology, Department of Pediatrics"},{"name":"Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"2021120905491189700_R1","doi-asserted-by":"crossref","unstructured":"Landier W, Wallace WH, Hudson MM. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatr Blood Cancer.2006;46(2):149\u2013158","DOI":"10.1002\/pbc.20612"},{"key":"2021120905491189700_R2","doi-asserted-by":"crossref","unstructured":"Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-term Follow-up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol.2004;22(24):4979\u20134990","DOI":"10.1200\/JCO.2004.11.032"},{"key":"2021120905491189700_R3","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA.2001;285(6):785\u2013795","DOI":"10.1001\/jama.285.6.785"},{"key":"2021120905491189700_R4","doi-asserted-by":"crossref","unstructured":"Aisenberg J, Hsieh K, Kalaitzoglou G, et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol.1998;20(3):241\u2013245","DOI":"10.1097\/00043426-199805000-00010"},{"key":"2021120905491189700_R5","doi-asserted-by":"crossref","unstructured":"French SA, Fulkerson JA, Story M. Increasing weight-bearing physical activity and calcium intake for bone mass growth in children and adolescents: a review of intervention trials. Prev Med.2000;31(6):722\u2013731","DOI":"10.1006\/pmed.2000.0758"},{"key":"2021120905491189700_R6","doi-asserted-by":"crossref","unstructured":"Tillmann V, Darlington AS, Eiser C, Bishop NJ, Davies HA. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res.2002;17(6):1073\u20131080","DOI":"10.1359\/jbmr.2002.17.6.1073"},{"key":"2021120905491189700_R7","doi-asserted-by":"crossref","unstructured":"van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol.2000;35(4):415\u2013420","DOI":"10.1002\/1096-911X(20001001)35:4<415::AID-MPO4>3.0.CO;2-9"},{"key":"2021120905491189700_R8","doi-asserted-by":"crossref","unstructured":"Warner JT, Evans WD, Webb DK, Bell W, Gregory JW. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res.1999;45(4 pt 1):544\u2013551","DOI":"10.1203\/00006450-199904010-00014"},{"key":"2021120905491189700_R9","doi-asserted-by":"crossref","unstructured":"Atkinson SA, Fraher L, Gundberg CM, Andrew M, Pai M, Barr RD. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr.1989;114(5):793\u2013800","DOI":"10.1016\/S0022-3476(89)80138-6"},{"key":"2021120905491189700_R10","doi-asserted-by":"crossref","unstructured":"Hochberg Z. Mechanisms of steroid impairment of growth. Horm Res.2002;58(suppl 1):33\u201338","DOI":"10.1159\/000064764"},{"key":"2021120905491189700_R11","doi-asserted-by":"crossref","unstructured":"Mandel K, Atkinson S, Barr RD, Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol.2004;22(7):1215\u20131221","DOI":"10.1200\/JCO.2004.04.199"},{"key":"2021120905491189700_R12","doi-asserted-by":"crossref","unstructured":"Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol.2000;18(7):1570\u20131593","DOI":"10.1200\/JCO.2000.18.7.1570"},{"key":"2021120905491189700_R13","doi-asserted-by":"crossref","unstructured":"Vassilopoulou-Sellin R, Brosnan P, Delpassand A, Zietz H, Klein MJ, Jaffe N. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol.1999;32(4):272\u2013278","DOI":"10.1002\/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G"},{"key":"2021120905491189700_R14","doi-asserted-by":"crossref","unstructured":"Leslie WD, Adler RA, El-Hajj Fuleihan G, et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions. J Clin Densitom.2006;9(1):22\u201330","DOI":"10.1016\/j.jocd.2006.05.004"},{"key":"2021120905491189700_R15","doi-asserted-by":"crossref","unstructured":"Leonard MB. Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques. Med Pediatr Oncol.2003;41(3):198\u2013207","DOI":"10.1002\/mpo.10337"},{"key":"2021120905491189700_R16","doi-asserted-by":"crossref","unstructured":"Clark EM, Tobias JH, Ness AR. Association between bone density and fractures in children: a systematic review and meta-analysis. Pediatrics.2006;117(2). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/2\/e291","DOI":"10.1542\/peds.2005-1404"},{"key":"2021120905491189700_R17","doi-asserted-by":"crossref","unstructured":"Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr.1995;126(4):557\u2013564","DOI":"10.1016\/S0022-3476(95)70349-7"},{"key":"2021120905491189700_R18","doi-asserted-by":"crossref","unstructured":"Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kroger H. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab.1999;84(9):3174\u20133181","DOI":"10.1210\/jcem.84.9.5968"},{"key":"2021120905491189700_R19","doi-asserted-by":"crossref","unstructured":"Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol.1998;20(3):234\u2013240","DOI":"10.1097\/00043426-199805000-00009"},{"key":"2021120905491189700_R20","doi-asserted-by":"crossref","unstructured":"Brennan BM, Rahim A, Adams JA, Eden OB, Shalet SM. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer.1999;79(11\u201312):1859\u20131863","DOI":"10.1038\/sj.bjc.6690296"},{"key":"2021120905491189700_R21","doi-asserted-by":"crossref","unstructured":"Hoorweg-Nijman JJ, Kardos G, Roos JC, et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol (Oxf).1999;50(2):237\u2013244","DOI":"10.1046\/j.1365-2265.1999.00654.x"},{"key":"2021120905491189700_R22","doi-asserted-by":"crossref","unstructured":"Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia.2001;15(5):728\u2013734","DOI":"10.1038\/sj.leu.2402078"},{"key":"2021120905491189700_R23","doi-asserted-by":"crossref","unstructured":"Kaste SC, Rai SN, Fleming K, et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer.2006;46(1):77\u201387","DOI":"10.1002\/pbc.20553"},{"key":"2021120905491189700_R24","doi-asserted-by":"crossref","unstructured":"Nysom K, Holm K, Hertz H, Muller J, Michaelsen KF, Molgaard C. Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol.2001;19(11):2970\u20132971","DOI":"10.1200\/JCO.2001.19.11.2970"},{"key":"2021120905491189700_R25","doi-asserted-by":"crossref","unstructured":"Barr RD, Simpson T, Webber CE, et al. Osteopenia in children surviving brain tumours. Eur J Cancer.1998;34(6):873\u2013877","DOI":"10.1016\/S0959-8049(98)00011-2"},{"key":"2021120905491189700_R26","doi-asserted-by":"crossref","unstructured":"Holzer G, Krepler P, Koschat MA, Grampp S, Dominkus M, Kotz R. Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg Br.2003;85(2):231\u2013237","DOI":"10.1302\/0301-620X.85B2.13257"},{"key":"2021120905491189700_R27","doi-asserted-by":"crossref","unstructured":"Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol.2001;19(12):3066\u20133072","DOI":"10.1200\/JCO.2001.19.12.3066"},{"key":"2021120905491189700_R28","doi-asserted-by":"crossref","unstructured":"Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res.1996;11(11):1774\u20131783","DOI":"10.1002\/jbmr.5650111122"},{"key":"2021120905491189700_R29","doi-asserted-by":"crossref","unstructured":"Henderson RC, Madsen CD, Davis C, Gold SH. Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol.1996;18(4):367\u2013371","DOI":"10.1097\/00043426-199611000-00006"},{"key":"2021120905491189700_R30","doi-asserted-by":"crossref","unstructured":"Hesseling PB, Hough SF, Nel ED, van Riet FA, Beneke T, Wessels G. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl.1998;11:44\u201347","DOI":"10.1002\/(SICI)1097-0215(1998)78:11+<44::AID-IJC13>3.0.CO;2-A"},{"key":"2021120905491189700_R31","doi-asserted-by":"crossref","unstructured":"Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood.2004;104(6):1898\u20131906","DOI":"10.1182\/blood-2004-03-1010"},{"key":"2021120905491189700_R32","doi-asserted-by":"crossref","unstructured":"Bhatia S, Ramsay NK, Weisdorf D, Griffiths H, Robison LL. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant.1998;22(1):87\u201390","DOI":"10.1038\/sj.bmt.1701275"},{"key":"2021120905491189700_R33","doi-asserted-by":"crossref","unstructured":"Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant.2004;33(4):435\u2013441","DOI":"10.1038\/sj.bmt.1704360"},{"key":"2021120905491189700_R34","doi-asserted-by":"crossref","unstructured":"Nysom K, Holm K, Michaelsen KF, et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant.2000;25(2):191\u2013196","DOI":"10.1038\/sj.bmt.1702131"},{"key":"2021120905491189700_R35","unstructured":"Stern JM, Chesnut CH 3rd, Bruemmer B, et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant.1996;17(3):395\u2013400"},{"key":"2021120905491189700_R36","doi-asserted-by":"crossref","unstructured":"Davies JH, Evans BA, Jenney ME, Gregory JW. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin Endocrinol (Oxf).2005;63(1):1\u20139","DOI":"10.1111\/j.1365-2265.2005.02263.x"},{"key":"2021120905491189700_R37","doi-asserted-by":"crossref","unstructured":"Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun.2005;328(3):688\u2013696","DOI":"10.1016\/j.bbrc.2004.11.097"},{"key":"2021120905491189700_R38","doi-asserted-by":"crossref","unstructured":"Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S. Clinical review: sex steroids and the periosteum\u2014reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab.2006;91(2):378\u2013382","DOI":"10.1210\/jc.2005-1766"},{"key":"2021120905491189700_R39","doi-asserted-by":"crossref","unstructured":"Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol.1999;33(1):2\u20138","DOI":"10.1002\/(SICI)1096-911X(199907)33:1<2::AID-MPO2>3.0.CO;2-7"},{"key":"2021120905491189700_R40","doi-asserted-by":"crossref","unstructured":"Meacham L. Endocrine late effects of childhood cancer therapy. Curr Probl Pediatr Adolesc Health Care.2003;33(7):217\u2013242","DOI":"10.1016\/S1538-5442(03)00053-1"},{"key":"2021120905491189700_R41","unstructured":"Hudson MM, Landier W, Bhatia S. Long-term Follow-up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. In: Children's Oncology Group, ed. Version 2.0. www.survivorshipguidelines.org. Accessed December 24,2007"},{"key":"2021120905491189700_R42","doi-asserted-by":"crossref","unstructured":"Go\u0301mez JM. The role of insulin-like growth factor I components in the regulation of vitamin D. Curr Pharm Biotechnol.2006;7(2):125\u2013132","DOI":"10.2174\/138920106776597621"},{"key":"2021120905491189700_R43","doi-asserted-by":"crossref","unstructured":"Sklar C, Boulad F, Small T, Kernan N. Endocrine complications of pediatric stem cell transplantation. Front Biosci.2001;6:G17\u2013G22","DOI":"10.2741\/A714"},{"key":"2021120905491189700_R44","doi-asserted-by":"crossref","unstructured":"Banfi A, Bianchi G, Galotto M, Cancedda R, Quarto R. Bone marrow stromal damage after chemo\/radiotherapy: occurrence, consequences and possibilities of treatment. Leuk Lymphoma.2001;42(5):863\u2013870","DOI":"10.3109\/10428190109097705"},{"key":"2021120905491189700_R45","doi-asserted-by":"crossref","unstructured":"Hopewell JW. Radiation-therapy effects on bone density. Med Pediatr Oncol.2003;41(3):208\u2013211","DOI":"10.1002\/mpo.10338"},{"key":"2021120905491189700_R46","doi-asserted-by":"crossref","unstructured":"Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys.2004;60(1):265\u2013274","DOI":"10.1016\/j.ijrobp.2004.02.001"},{"key":"2021120905491189700_R47","doi-asserted-by":"crossref","unstructured":"Wagner LM, Neel MD, Pappo AS, et al. Fractures in pediatric Ewing sarcoma. J Pediatr Hematol Oncol.2001;23(9):568\u2013571","DOI":"10.1097\/00043426-200112000-00003"},{"key":"2021120905491189700_R48","doi-asserted-by":"crossref","unstructured":"Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab.2000;85(9):3227\u20133232","DOI":"10.1210\/jc.85.9.3227"},{"key":"2021120905491189700_R49","doi-asserted-by":"crossref","unstructured":"Mattano L. The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting. Pediatr Transplant.2003;7(suppl 3):71\u201375","DOI":"10.1034\/j.1399-3046.7.s3.11.x"},{"key":"2021120905491189700_R50","doi-asserted-by":"crossref","unstructured":"Mu\u0308ller HL, Schneider P, Bueb K, et al. Volumetric bone mineral density in patients with childhood craniopharyngioma. Exp Clin Endocrinol Diabetes.2003;111(3):168\u2013173","DOI":"10.1055\/s-2003-39789"},{"key":"2021120905491189700_R51","doi-asserted-by":"crossref","unstructured":"Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C. Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol.2001;37(6):518\u2013524","DOI":"10.1002\/mpo.1245"},{"key":"2021120905491189700_R52","doi-asserted-by":"crossref","unstructured":"Cromer B, Harel Z. Adolescents: at increased risk for osteoporosis?Clin Pediatr (Phila).2000;39(10):565\u2013574","DOI":"10.1177\/000992280003901001"},{"key":"2021120905491189700_R53","doi-asserted-by":"crossref","unstructured":"Kadan-Lottick N, Marshall JA, Baron AE, Krebs NF, Hambidge KM, Albano E. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr.2001;138(6):898\u2013904","DOI":"10.1067\/mpd.2001.113102"},{"key":"2021120905491189700_R54","unstructured":"National Institutes of Health, Office of Dietary Supplements. Dietary supplement fact sheet: calcium. Available at: http:\/\/ods.od.nih.gov\/factsheets\/calcium.asp. Accessed December 3,2007"},{"key":"2021120905491189700_R55","doi-asserted-by":"crossref","unstructured":"Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med.1993;328(12):833\u2013838","DOI":"10.1056\/NEJM199303253281203"},{"key":"2021120905491189700_R56","doi-asserted-by":"crossref","unstructured":"Hess B. Nutritional aspects of stone disease. Endocrinol Metab Clin North Am.2002;31(4):1017\u20131030, ix\u2013x","DOI":"10.1016\/S0889-8529(02)00029-4"},{"key":"2021120905491189700_R57","doi-asserted-by":"crossref","unstructured":"Barr RD, Guo CY, Wiernikowski J, Webber C, Wright M, Atkinson S. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with pamidronate. Med Pediatr Oncol.2002;39(1):44\u201346","DOI":"10.1002\/mpo.10057"},{"key":"2021120905491189700_R58","doi-asserted-by":"crossref","unstructured":"Kelly J, Damron T, Grant W, et al. Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers. J Pediatr Hematol Oncol.2005;27(5):248\u2013253","DOI":"10.1097\/01.mph.0000162526.77400.78"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/e705\/1123502\/zpe0030800e705.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/e705\/1123502\/zpe0030800e705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:39:25Z","timestamp":1639093165000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/3\/e705\/72832\/Bone-Mineral-Density-Deficits-in-Survivors-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,3,1]]},"published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-1396","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}